-
Personalized Medicine will create many answers and solutions in healthcare, but will we have the money to afford it? I post quite a bit about genomics and personalized medicine on the blog here and the one thing it has in common with the rest of healthcare is cost. The success of personalized...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-14-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, healthcare, Medical Records, FDA, integration, CMS, Leavitt
-
Yes there is a genomics based test for this now, male and female. Inquiring minds want to know. If the answer comes back yes, then get a hold of some Propecia ©. If you have the gene variant, you have approximately a 70% chance of going bald, and the same in reverse if you do not have...
-
The economy is also affecting some of the work and business design of genetic companies. DeCode is is Iceland with offices here in Illinois as well. Biotech companies are starting to feel the crunch as well, even those with breakthrough technology in personalized medicine and part of what...
-
However, their prescription drug unit faced the same problems as the rest of the Pharma industry. A smart investment in consumer products is helping hold things together for J and J. The consumer product division was purchased from Pfizer in 2006, which was the company purchased by Pfizer...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-14-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, personalized medicine, Genomics, Pharma, Pfizer, Phamaceuticals, Consumer Goods, J and J, Warner Lambert
-
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-13-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
-
It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-07-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
-
We are getting closer to the $1,000 genome. Their business though is not to sell the machines, but rather to “wholesale” the process, in other words they will sequence only and offer no interpretations, which would be done by another company they would supply the sequencing information to. ...
-
How hot is genomics today? There are several manufacturers of the machines that will accomplish running our DNA, our complete DNA. I know to the average person this gets a little confusing, but the companies listed here are the companies that manufacture the machines that do the entire work...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-25-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, Genomics, Biotech, Pharmacogenomics, DNA Testing, Helicos, Sequencing, RNA
-
No we do hold the monopoly on this technology in the US, and this article brings to light that genomics is a global concern and effort. BD Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations...
-
I think many might agree here, as Intellectual Property is getting pretty gray these days. Software companies seem to have a better handle on this, but they even face challenges too. Once you share intellectual property, the cat's out of the bag per se. Add on some economic constraints...
-
Interesting correlation on how the move business and Pharma share similar business plans when it comes to producing a blockbuster drug. R and D, yup, got high costs with both, unpredictable, yup, nobody knows until the release, budgets and flops, well it could be a toss up over which industry can...
-
Only requires a blood sample, but the cost is not cheap, but neither is a heart transplant. If one were having a transplant, this could be very valuable to know up front about potential rejection issues that would arise after the fact. BD The Food and Drug Administration said the test...
-
Patrice Milos, Vice President and Chief Scientific Officer, Helicos Biosciences This week I had the opportunity to talk with Patrice Milos from Helicos Biosciences who has a long background in global research and spent a number of years at Pfizer as Executive Director at Pfizer Global Research and Development...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-15-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, DNA Testing, Phamaceuticals, Helios
-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
You set up a profile and play against others on the Internet..." The more we know about how certain proteins fold, the better new proteins we can design to combat the disease-related proteins and cure the diseases.". The project has been given a grant of 20 Million from the Bill and Melinda...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-11-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, Games, personalized medicine, DNA, Genomics, Disease Research, FoldIt, University of Washington, Proteins